Treatment patterns in UK adult patients with atopic dermatitis treated with systemic immunosuppressants: data from The Health Improvement Network (THIN)

References

• Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387:1109–1122.
   PubMed Web of Science ®Google Scholar
• Thomsen SF. Atopic dermatitis: natural history, diagnosis, and treatment. ISRN Allergy. 2014;2014:1.
   Google Scholar
• Garmhausen D, Hagemann T, Bieber T, et al. Characterization of different courses of atopic dermatitis in adolescent and adult patients. Allergy. 2013;68:498–506.
   PubMed Web of Science ®Google Scholar
• Simpson EL, Bieber T, Eckert L, et al. Patient burden of moderate to severe atopic dermatitis (AD): insights from a phase 2b clinical trial of dupilumab in adults. J Am Acad Dermatol. 2016;74:491–498.
   PubMed Web of Science ®Google Scholar
• Guttman-Yassky E, Simpson E, Margolis DJ, et al. Patient-reported disease burden in adults with atopic dermatitis: a US cross-sectional study. 25th European Academy of Dermatology and Venereology; 2016 Sep 28–Oct 2; Vienna, Austria; 2016.
   Google Scholar
• Eckert L, Gupta S, Amand C, et al. Impact of atopic dermatitis on health-related quality of life and productivity in adults in the United States: an analysis using the National Health and Wellness Survey. J Am Acad Dermatol. 2017;77:274–279.
   PubMed Web of Science ®Google Scholar
• Girolomoni G, Gadkari A, Auziere S, et al. The patient-reported disease burden in adults with atopic dermatitis: a cross-sectional study in Canada and Europe. Value Health. 2017;20:A807.
   Google Scholar
• Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71:116–132.
   PubMed Web of Science ®Google Scholar
• Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70:338–351.
   PubMed Web of Science ®Google Scholar
• Sidbury R, Davis DM, Cohen DE, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71:327–349.
   PubMed Web of Science ®Google Scholar
• Ring J, Alomar A, Bieber T, et al. Guidelines for treatment of atopic eczema (atopic dermatitis). Part II. J Eur Acad Dermatol Venereol. 2012;26:1176–1193.
   PubMed Web of Science ®Google Scholar
• Roekevisch E, Spuls PI, Kuester D, et al. Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review. J Allergy Clin Immunol. 2014;133:429–438.
   PubMed Web of Science ®Google Scholar
• Akhavan A, Rudikoff D. Atopic dermatitis: systemic immunosuppressive therapy. Semin Cutan Med Surg. 2008;27:151–155.
   PubMed Web of Science ®Google Scholar
• Bieber T, Straeter B. Off-label prescriptions for atopic dermatitis in Europe. Allergy. 2015;70:6–11.
   PubMed Web of Science ®Google Scholar
• Jorga A, Holt DW, Johnston A. Therapeutic drug monitoring of cyclosporine. Transplant Proc. 2004;36:396S–403S.
   PubMed Web of Science ®Google Scholar
• Behnam SM, Behnam SE, Koo JY. Review of cyclosporine immunosuppressive safety data in dermatology patients after two decades of use. J Drugs Dermatol. 2005;4:189–194.
   PubMedGoogle Scholar
• Schmitt J, Schmitt N, Meurer M. Cyclosporin in the treatment of patients with atopic eczema – a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2007;21:606–619.
   PubMed Web of Science ®Google Scholar
• OPEN Health. The UK Health Improvement Network (THIN); [cited 2017 Jun 5]. Available from: http://www.openhealth.co.uk/news/2017/thin-data-the-health-improvement-network.aspx
   Google Scholar
• European Federation of Allergy and Airways Diseases Patients’ Associations. Atopic eczema: itching for life. Quality of life and costs for people with severe atopic eczema in Europe; 2018; [cited 2018 Nov 15]. Available from: http://www.efanet.org/images/2018/EN_-_Itching_for_life_Quality_of_Life_and_costs_for_people_with_severe_atopic_eczema_in_Europe_.pdf
   Google Scholar
• University of Birmingham. More about THIN; 2019; [cited 2019 Apr 15]. Available from: https://www.birmingham.ac.uk/research/activity/mds/projects/HaPS/PCCS/THIN/more-about-thin/index.aspx
   Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
   PubMedGoogle Scholar
• Taylor K, Swan DJ, Affleck A, et al. Treatment of moderate-to-severe atopic eczema in adults within the U.K.: results of a national survey of dermatologists. Br J Dermatol. 2017;176:1617–1623.
   PubMed Web of Science ®Google Scholar
• Tidman MJ, Smith CJ. Principles of systemic therapy. In: Griffiths CE, Barker JN, Bleiker T, et al. editors. Rook's textbook of dermatology. Oxford: John Wiley & Sons; 2015. Available from: http://www.rooksdermatology.com/manual/c19-sec-0201?view=chapter
   Google Scholar
• Ardern-Jones MR, Hampton P, Vleugels RA. Handbook of dermatology treatments. London: JP Medical Publishers; 2017.
   Google Scholar
• British National Formulary – National Institute for Health and Care Excellence (NICE). Ciclosporin; [2017 Jun 20]. Available from: https://bnf.nice.org.uk/drug/ciclosporin.html
   Google Scholar
• Schram ME, Borgonjen RJ, Bik CM, et al. Off-label use of azathioprine in dermatology. Arch Dermatol. 2011;147:474–488.
   PubMedGoogle Scholar
• Meggitt SJ, Gray JC, Reynolds NJ. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial. Lancet. 2006;367:839–846.
   PubMed Web of Science ®Google Scholar
• Meggitt SJ, Anstey AV, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the safe and effective prescribing of azathioprine 2011. Br J Dermatol. 2011;165:711–734.
   PubMed Web of Science ®Google Scholar
• Schram ME, Roekevisch E, Leeflang MM, et al. A randomized trial of methotrexate versus azathioprine for severe atopic eczema. J Allergy Clin Immunol. 2011;128:353–359.
   PubMed Web of Science ®Google Scholar
• British Association of Dermatologists (BAD). Phototherapy service guidance 2017; [cited 2018 Mar 21]. Available from: http://www.bad.org.uk/shared/get-file.ashx?itemtype=document&id=4151
   Google Scholar
• Chaplin S. Guide to treatments used for atopic dermatitis in adults. Prescriber. 2016;27:30–39.
   Google Scholar
• European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1993;186:23–31.
   PubMed Web of Science ®Google Scholar
• Hanifin JM, Thurston M, Omoto M, et al. The Eczema Area and Severity Index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol. 2001;10:11–18.
   PubMed Web of Science ®Google Scholar
• Lewis JD, Schinnar R, Bilker WB, et al. Validation studies of The Health Improvement Network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf. 2007;16:393–401.
   PubMed Web of Science ®Google Scholar
• Denburg MR, Haynes K, Shults J, et al. Validation of The Health Improvement Network (THIN) database for epidemiologic studies of chronic kidney disease. Pharmacoepidemiol Drug Saf. 2011;20:1138–1149.
   PubMed Web of Science ®Google Scholar
• Martin-Merino E, Fortuny J, Rivero E, et al. Validation of diabetic retinopathy and maculopathy diagnoses recorded in a U.K. primary care database. Diabetes Care. 2012;35:762–767.
   PubMed Web of Science ®Google Scholar
• Blak BT, Thompson M, Dattani H, et al. Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care. 2011;19:251–255.
   PubMedGoogle Scholar
• Diwakar L, Cummins C, Ryan R, et al. Prescription rates of adrenaline auto-injectors for children in UK general practice: a retrospective cohort study. Br J Gen Pract. 2017;67:e300–e305.
   PubMed Web of Science ®Google Scholar
• Sharma M, Nazareth I, Petersen I. Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study. BMJ Open. 2016;6:e010210.
   PubMed Web of Science ®Google Scholar
• Khalid JM, Globe G, Fox KM, et al. Treatment and referral patterns for psoriasis in United Kingdom primary care: a retrospective cohort study. BMC Dermatol. 2013;13:9.
   PubMedGoogle Scholar
• James GD, Petersen I, Nazareth I, et al. Use of long-term antibiotic treatment in COPD patients in the UK: a retrospective cohort study. Prim Care Respir J. 2013;22:271–277.
   PubMedGoogle Scholar